Genomic Analysis of a Strain Collection Containing Multidrug-, Extensively Drug-, Pandrug-, and Carbapenem-Resistant Modern Clinical Isolates of Acinetobacter baumannii.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
20 09 2022
Historique:
pubmed: 16 8 2022
medline: 24 9 2022
entrez: 15 8 2022
Statut: ppublish

Résumé

In this study, we characterize a new collection that comprises multidrug-resistant (MDR), extensively drug-resistant (XDR), pandrug-resistant (PDR), and carbapenem-resistant modern clinical isolates of Acinetobacter baumannii collected from hospitals through national microbiological surveillance in Belgium. Bacterial isolates (

Identifiants

pubmed: 35969073
doi: 10.1128/aac.00892-22
pmc: PMC9487538
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
Interleukin-1 Receptor-Like 1 Protein 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0089222

Références

BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
J Bacteriol. 2015 Jun 15;197(12):2027-35
pubmed: 25845845
mBio. 2022 Apr 26;13(2):e0275921
pubmed: 35311529
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Jan;38(1):11-15
pubmed: 31060865
Antimicrob Agents Chemother. 2015;59(6):3602-5
pubmed: 25801566
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
mSphere. 2020 Apr 1;5(2):
pubmed: 32238571
Clin Microbiol Infect. 2006 Sep;12(9):826-36
pubmed: 16882287
Bioinformatics. 2018 Aug 1;34(15):2666-2669
pubmed: 29547981
Trends Microbiol. 2022 Feb;30(2):199-200
pubmed: 34836792
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
J Clin Microbiol. 2006 Nov;44(11):4189-92
pubmed: 16957031
Microb Drug Resist. 2018 Jan/Feb;24(1):48-54
pubmed: 28570118
Antibiotics (Basel). 2017 Nov 21;6(4):
pubmed: 29160808
Microb Genom. 2019 Oct;5(10):
pubmed: 31599224
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
J Antimicrob Chemother. 2010 Feb;65(2):233-8
pubmed: 19996144
Antimicrob Agents Chemother. 2016 Jan 11;60(3):1801-18
pubmed: 26824943
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5724-30
pubmed: 27431216
Clin Microbiol Rev. 2008 Jul;21(3):538-82
pubmed: 18625687
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Clin Microbiol Rev. 2007 Jul;20(3):440-58, table of contents
pubmed: 17630334
J Antimicrob Chemother. 2017 Oct 1;72(10):2708-2714
pubmed: 29091183
Genome Biol. 2021 Jan 8;22(1):28
pubmed: 33419473
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
J Antimicrob Chemother. 2021 Jan 1;76(1):101-109
pubmed: 33009809
Infect Genet Evol. 2018 Mar;58:243-250
pubmed: 29320720
mSphere. 2020 Jan 15;5(1):
pubmed: 31941816
Ann Clin Microbiol Antimicrob. 2021 Mar 20;20(1):19
pubmed: 33743736
J Hosp Infect. 2021 Jun;112:54-60
pubmed: 33640370
Clin Microbiol Rev. 2017 Jan;30(1):409-447
pubmed: 27974412
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29463529
Microb Drug Resist. 2017 Oct;23(7):864-870
pubmed: 28437227
Euro Surveill. 2012 Mar 15;17(11):
pubmed: 22449866
Int J Antimicrob Agents. 2018 Dec;52(6):916-921
pubmed: 29857033
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Front Microbiol. 2017 Feb 06;8:163
pubmed: 28220115
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063

Auteurs

Adam Valcek (A)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brusselgrid.8767.e (VUB), Brussels, Belgium.

Kristina Nesporova (K)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.

Clémence Whiteway (C)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brusselgrid.8767.e (VUB), Brussels, Belgium.

Tim De Pooter (T)

Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Wouter De Coster (W)

Applied and Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Applied and Translational Neurogenomics Group, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Mojca Strazisar (M)

Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.

Charles Van der Henst (C)

Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Structural Biology Brussels, Vrije Universiteit Brusselgrid.8767.e (VUB), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH